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Abstract 
Objective: To investigate gender-specific trajectories in well-being among older people with 
coronary heart disease (CHD) and to compare them to those of healthy people. 
Method: 4,496 participants from the first three waves of the English Longitudinal Study of 
Ageing (2002/03-2006/07). We measured well-being using quality of life (CASP-19) and 
depressive caseness (3 or more symptoms on the CESD-8). 
Results: After adjustment, at 2 and 4 years follow-up women had 3 points higher quality of 
life than men (p<0.001). When looking at each quality of life’s domain we found that women 
reported higher scores of Autonomy compared to men. The gender difference in the probability 
of having depressive caseness reduced to 7 percentage points at 4-year follow-up from 13 
percentage points in the previous occasions. Men’s quality of life declined progressively over-
time by 3 points (p<0.001) (equivalent to the effect of having diabetes) but no changes in 
prevalence of depressive caseness were found. Women’s quality of life only declined after 4-
year follow-up by less than 2 points (p<0.001), while in the same period their probability of 
reporting depressive caseness reduced by 6 percentage points (p<0.001). 
Conclusions: Women had better quality of life than men in the two and four years following a 
CHD event, and were not more likely than men to report depressive caseness in the long term. 
Men’s quality of life deteriorated progressively over time, among women it did not deteriorate 
in the first two years following a CHD event; women had a long-term improvement in 
depressive caseness. 
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INTRODUCTION 
Recent trends indicate that the death rate from coronary heart disease (CHD) reduced by at 
least two fifths between 2000 and 2010 for men and women aged 55 to 64 in the UK (British 
Heart Foundation, 2010). Concurrent with the substantial reduction in deaths from CHD, there 
has been a growing recognition of the importance of outcomes other than survival following 
CHD, such as well-being. Reduced quality of life and increased risk of depression are common 
following CHD (Kristofferzon et al., 2005; Norris et al., 2007) and are associated with 
increased mortality (Lesperance et al., 1996; 2000; Ziegelstein et al., 2000; Bogg et al., 2000; 
Ferketich et al., 2000; Bush et al., 2001; Carney et al., 2003; Lane et al.; 2005; Parashar  et al., 
1996), with poor adherence to recommended behaviours and lifestyle changes after the cardiac 
event (Ziegelstein et al., 2000; 2001) and with an increased risk of readmission because of 
cardiac complications (Lauzon et al., 2003). 
Results from studies exploring longitudinal changes in well-being among men and women 
hospitalized after CHD reported that women had significantly lower health-related quality of 
life than men (Norris et al., 2007; Bogg et al., 2000; Westin et al., 1999; Brink et al., 2005) and 
were more likely to be depressed (Norris et al., 2007) one year post-CHD. However, other 
studies reported contrasting findings, with no difference between men and women in their 
prevalence of depression post-CHD (Brink et al., 2005; Wiklund  et al., 1993). Results from a 
community study with a five year follow-up showed that women had a high initial risk for 
depression with a significant decrease after two years, while the risk for depression for men 
was only increased in the two to five years after myocardial infarction (Bjerkeset et al., 2005).  
Despite the increasing interest in the well-being of people with CHD (Norris et al., 2007, 
Norris et al., 2007; Bogg et al., 2000; Westin et al., 1999; Brink et al., 2005; Wiklund  et al., 
1993; Bjerkeset et al., 2005), results from the majority of previous studies have mainly been 
based on small samples with short follow-up periods (Norris et al., 2007,7, Bogg et al., 2000; 
Westin et al., 1999; Brink et al., 2005; Wiklund  et al., 1993). Research has typically focused 
exclusively on people with CHD, so direct comparisons with a population free from CHD and 
other major diseases on well-being have not been possible. Therefore, questions concerning 
long-term outcome, gender differences, and the role of explaining factors still remain 
unanswered. Moreover, most of the studies have measured quality of life using a health-related 
measure such as the short-form-36, which may not be optimal as these measures are based on 
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proxies (such as health) “which draw on a set of normative assumptions about what a 
particular condition implies for a person’s quality of life without necessarily taking close 
account of a person’s current life experience” (Wiggins et al., 2008).  A recent avenue of 
research looks at positive, rather than negative functioning and this is particularly interesting 
given that health life expectancy has been improving. Given this interest, an alternative 
measure of quality of life has been specifically developed for old age, called CASP (Hyde et 
al., 2003), comprising four domains ('control', 'autonomy', 'pleasure' and 'self-realization'). 
CASP has been based on theories of need satisfaction (Doyal and Gough, 1991), which assume 
that quality of life at older ages is conceptualized as the degree to which human needs are 
satisfied in the above mentioned four domains (Hyde et al., 2003). This measure differs from 
health-related measures by focusing on positive aspects of quality of life and by being 
independent of health and other factors that might influence it (Hyde et al., 2003; Wiggins et 
al., 2008). 
Using a large population-based sample of older adults living in England, the aims of our 
study are to explore gender-specific changes in well-being over a six year period among people 
with CHD and to compared them with a group of individuals free from CHD and other major 
conditions. In line with current recommendations to distinguish between different aspects of 
well-being (Dolan et al., 2011; Kahneman et al., 2006)  we use quality of life, and depressive 
caseness.  
METHODS 
Study population 
We analysed data from the first three waves (2002-2003 to 2006-2007) of the English 
Longitudinal Study of Ageing (ELSA) (Steptoe et al., 2012), a panel study where the same 
individuals are re-interviewed every two years. The ELSA sample was designed to represent 
people aged 50 and over, living in private households in England. The original sample size was 
11,391 at wave 1 (2002-03) (individual response rate of 67%). The analytical sample of this 
study consists of 4,996 participants with a CHD event occurring (n=895 18%) in the two years 
preceding the baseline interview (2002-03) and of healthy participants without known 
longstanding conditions (n=3,601) at baseline. A detailed explanation of the selection of the 
CHD and healthy participants is given in the next section. Data were collected through face-
to-face interviews and self-completion questionnaires. Ethical approval for the ELSA study 
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was provided by the local Ethics Committee and patients or their representatives gave informed 
consent. 
Measures 
Well-being 
We measured quality of life using the CASP-19 (Hyde et al., 2003) self-completion 
questionnaire. CASP-19 contains 19 items covering four conceptual domains of individual 
needs that are particularly relevant in later life: Control, Autonomy, Self-realization and 
Pleasure. The instrument has four items for the control domain and five for each of the others. 
Each item is assessed on a four-point Likert scale. The resulting scale scores of Control (range 
0 to 12, mean 8.6 s.d 2.5), Autonomy (range 1 to 15, mean 10.8 s.d. 2.6), Self-realization (range 
0 to 15, mean 10.6 s.d. 3.1) and Pleasure (range 0 to 15, mean 13.5 s.d. 2.1) are summed to 
form an index which ranges from 0 to 57 with higher scores indicating better quality of life 
(sample specific Cronbach’s alpha=0.78). The psychometric properties of CASP-19 are fully 
described elsewhere (Hyde et al., 2003; Wiggins et al., 2008). In terms of size of effects, a 
reduction of around 7 quality of life points is associated with having a limiting long-standing 
illness compared to those without (Netuveli et al., 2006).  
We used the eight-item version of the Centre for Epidemiologic Study Depression scale 
(CESD-8) administered in the face-to-face interview to measure depressive symptoms 
(Radloff, 1977). The questions asked the degree to which the respondent had experienced (or 
not) depressive symptoms such as restless sleep and being unhappy, over the past month. The 
total score, which ranges from 0 to 8, was dichotomized with score ≥3 to indicate depression 
caseness, in line with previous studies that have used this abridged version of the scale 
(Steffick, 2000; Chou, 2007; Blane et al., 2008; Rice et al., 2009).  Caseness does not here 
signify diagnosed depression. The dichotomy was used in preference to a continuous scale 
because of the skewed distribution of number of symptoms. 
Coronary Heart Disease 
Our main exposure was experience of angina and/or a myocardial infarction (henceforth 
referred to as coronary heart diseases CHD) during the two years prior to baseline. Exposure 
was identified from the face-to-face interview in which participants were asked whether a 
doctor had ever told them that they suffered from angina or heart attack and, if so, whether they 
had angina symptoms or myocardial infarction in the past two years. We compared people with 
CHD with a reference population of individuals that at baseline  had never been diagnosed with 
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CHD, stroke, diabetes, hypertension, pulmonary disease, Alzheimer, Parkinson’s, cancer and 
did not report any limiting longstanding illness (referred to Healthy group). The CHD and 
Healthy groups include people who might experience CHD and other chronic diseases after 
baseline. 
Covariates 
Covariates considered in this study include: gender, age, cohabiting status (0”cohabiting 
with a partner (married or not)” 1”not cohabiting with a partner”), employment status (three 
categories, paid employment, completely retired and other), educational attainment (0”yes” 
1”no”), quintile of non-pension wealth, smoking status (0”never smoked and ex-smoker” 
1”current smoker”), frequency of alcohol consumption (0”less than three times a week” 1”three 
times a week and more”), physical activity (0”physically active” 1”inactive”)  whether or not 
often troubled with pain, one or more limitation with activities of daily living (ADLs), score of 
positive support (Stafford et al., 2011) received from spouse, children, other relatives and 
friends(continuous variable with higher scores indicating greater positive support), and number 
of close friends (continuous variable). These time-varying factors were selected as relevant to 
the well-being outcomes included in the analyses.  
Statistical Analysis 
We used random intercepts models (Goldstein, 2003) to examine changes in well-being over 
time. First, we estimated a linear random intercepts model for quality of life using the index 
score obtained from the sum of the scores of each domains, Control, Autonomy, Self-
realisation and Pleasure. We then estimated linear random intercepts models for each of the 
four domains in order to explore whether different trajectories for the four distinct domains 
emerge. Lastly a logit random intercepts model was estimated for depressive caseness. The 
models included an interaction term between gender and time in order to assess gender-specific 
changes in the outcomes over time. The models were run separately for the CHD and Healthy 
groups. From the logit random intercepts model, average predicted probabilities were estimated 
and presented graphically, in the text they were referred to as percentages (probabilities 
multiplied by 100). 
To handle missing data due to loss to follow-up and item non-response we used a multiple 
imputation technique suitable for longitudinal data: the recently proposed two-fold fully 
conditional specification (Nevalainen et al., 2009). We created five imputed data sets and we 
combined the results estimates according to Rubin’s rule (1996). When using multiple 
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imputation methods it is recommended to include auxiliary variables predictive of missingness 
in the imputation model (Sterne et al., 2009) even if they are not of interest in the substantive 
model. We therefore added five variables (measured at baseline) which were found to be 
predictive of non-response (Scholes et al., 2008)  to the imputation model, these variables are: 
year of HSE interview, Government Office Region, housing tenure, number of people in the 
household and ethnicity. Statistical significance was assessed with a p-value ≤0.01, whereas a 
p-value up to 0.05 was considered as borderline significant. All analyses were run in Stata 
version 11.1.  
RESULTS 
Table 1 shows baseline characteristics of participants by disease status and gender. Men and 
women with CHD were on average older and had lower quality of life than men and women 
from the Healthy group. The prevalence of those reporting depressive caseness was higher in 
men and women with CHD compared to people in the Healthy group. The prevalence of being 
retired, in low education, with poor wealth, physically inactive, drinking alcohol on three or 
more days a week, often troubled with pain and with one or more limitations with ADLs was 
higher in men and women with CHD compared with men and women from the Healthy group.  
Women with CHD were also more likely than women from the Healthy group not to be 
cohabiting and less likely to be in the richest quintiles of wealth (5th and 4th). Men with CHD 
received on average lower positive social support than men from the Healthy group. 
Changes in quality of life 
Table 2 reports the changes over time in quality of life by gender among people with CHD 
and the Healthy group obtained using random intercepts models (imputed data), results are 
presented fully adjusted. Figure 1 shows graphically the results reported in Table 2. Among 
men with CHD the adjusted mean quality of life score at baseline was 47.4, which decreased 
to 46.5 at two year follow-up (borderline significant p=0.034) and to 44.6 at four year follow-
up (p<0.001). The adjusted mean quality of life score at baseline for women with CHD was 
48.2, which remained stable at two year follow-up (48.4), and then decreased to 46.5 at four 
year follow-up (p<0.001). At two year follow-up and at four year follow-up women had 
significantly higher quality of life than men (2004-05: coeff 1.82 95%CI 0.83-2.81, p<0.001; 
2006-07: coeff 1.82 95%CI 0.83- 2.80 p<0.001) (Table 2 and Figure 1). 
Among men and women in the Healthy group, quality of life decreased substantially over 
time (Table 2 and Figure 1). Men and women in the Healthy group had similar changes in 
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quality of life over time and only at two year follow-up was the quality of life of women slightly 
higher than that of men (2004-05: coeff 0.49 95%CI 0.36-0.93 p=0.016); the difference was 
borderline significant and not clinically important.  
The adjusted quality of life of men with CHD was over 1.4 points lower than the quality of 
life of men from the Healthy group, at each measurement occasion. The adjusted quality of life 
of women with CHD was 1.1 points lower than the quality of life of women from the Healthy 
group at baseline, while at two and four year follow-ups it was almost the same.  
Table 3 shows changes over time in each domain of quality of life by gender among people 
with CHD and the Healthy group. To simplify interpretation results are presented as fully 
adjusted mean estimated using random intercepts models (imputed data). For each domain of 
quality of life, the score decreases over time in men and women from CHD group and from the 
Healthy group. The Autonomy domain is the aspect of quality of life for which men and women 
in the CHD group reported gender differences, while for the other domains the results were not 
statistically significant. Among people in the healthy group, only at wave 2 (2004-05) women 
reported higher scores of Autonomy compared to men, while on all other occasions and for all 
other domains of quality of life they reported similar results. 
Changes in depressive caseness 
Changes in prevalence of depressive caseness estimated using adjusted random intercepts 
models are presented in Table 4. Women with CHD had higher odds of depressive caseness 
than men at baseline and two-year follow-up, independent of covariates adjustment (2002-03: 
OR 1.99 95%CI 1.24-3.19 p<0.01; 2004-05: OR 1.76 95%CI 1.08-2.86 p=0.023). The odds of 
depressive caseness were constant over time among men with CHD, while women with CHD 
were less likely to report depressive caseness at four year follow-up compared to baseline, 
however, the difference was borderline significant (OR: 0.63 95%CI 0.40-0.97 p=0.024). 
From the models presented in Table 4 we estimated the adjusted predicted probabilities of 
depressive caseness and presented these results graphically in Figure 2. The probabilities are 
presented in the text as percentages. The probabilities of depressive caseness were fairly 
constant over time for men with CHD and men and women from the Healthy group. For women 
with CHD the prevalence of depressive caseness was constant between baseline and two-year 
follow-up but was 8 percentage points lower at four year follow-up (2006-07) compared to 
baseline (p<0.001). At baseline and at two year follow-up women had 13 percentage points 
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higher probability of reporting depressive caseness compared to men (p=0.023), this difference 
reduced to 7 percentage points at four year follow-up (p=0.517). 
After adjusting for covariates, men with CHD had 10 percentage points higher probability 
of depressive caseness  compared with in the Healthy group only at four year follow-up 
(p=0.024). Baseline differences in depressive caseness between people with CHD and those in 
the Healthy group, shown in Table 1, were no longer statistically significant when the model 
was adjusted for covariates. At each assessment women with CHD had the same probability of 
reporting 3 or more depressive symptoms as women from the Healthy group after adjustment. 
Gender differences in depressive caseness were found at each assessment in the Healthy group. 
DISCUSSION 
In this large population-based study of older people living in England we found gender-
specific changes over time for quality of life and depressive caseness among people with CHD. 
For men, quality of life decreased progressively over time by approximately three points 
(which in the whole ELSA sample is equivalent to the effect of having diabetes), while for 
women it remained stable in the first two years, only declining at four year follow-up by less 
than two points.  We showed that at two year follow-up and four year follow-up women had 
on average three points higher quality of life than men. It was found that the domain of quality 
of life for which men and women report differences is Autonomy. 
Changes in prevalence of 3 or more depressive symptoms also differed according to gender. 
The probability of this depressive caseness did not change significantly over time for men. For 
women the   prevalence at two year follow-up was the same as at baseline, while at four year 
follow-up prevalence had reduced below the baseline level. We found gender differences in 
depressive caseness independent of covariates at baseline and at two year follow-up but not at 
four year follow-up.  
In the Healthy group men and women reported similar trajectories of quality of life and 
depressive caseness. Women were more likely than men to have depressive caseness at each 
assessment; whereas quality of life only differed by gender at two year follow-up and was 
higher for women than men.. 
After adjustment we found that men with CHD had lower quality of life than men from the 
Healthy group at each follow-up, while their probability of depressive caseness was higher at 
four year follow-up only. Women with CHD had lower quality of life than women in the 
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Healthy group at baseline but no significant differences were found in depressive caseness at 
any time. 
Our finding of no gender differences in quality of life at baseline is in agreement with two 
earlier studies of myocardial infarction patients (Kristofferzon et al., 2005; Mendes de Leon et 
al., 2001). Our study is the first to show that women’s quality of life is better than men’s quality 
of life in the two and four years following a CHD event. To our knowledge, this study is also 
the first to show that women’s quality of life does not deteriorate in the first two years following 
a CHD event, while men’s quality of life deteriorated progressively over time. 
Our observation that women are more likely than men to report depressive caseness 
following a CHD event is well-known (Forrester  et al., 1992; Mallik et al., 2006) However, 
this study is the first to show that in unadjusted analyses gender differences are present at 
baseline and at two year follow-up but not at four year follow-up. The gender difference in 
depressive caseness disappeared after adjustment for covariates, implying that it was other 
characteristics rather than gender per se that led to the observed difference in crude analysis. 
Only one previous study reported that gender differences in the mental health dimension of 
health-related quality of life found at one year post-myocardial infarction did not persist once 
the model was adjusted for demographic, clinical, comorbid and psychosocial covariates 
(Norris et al., 2007). Our finding of an improvement in depressive caseness in women is 
somewhat in line with the study of Bjerkeset et al., (2005) which showed that women had a 
significant decrease in the risk of depressive symptoms (measured using a cut-off of 8 and more 
symptoms on the Hospital Anxiety and Depression rating Scale) two year post-myocardial 
infarction.  
We found that among people with CHD, depressive caseness was constant over time among 
men while women reported an improvement. Quality of life decreased in both men and women 
in the long term, although for women the decrease was less important. It is possible that 
depressive caseness reflected the immediate psychological reaction to the cardiac event, while 
the long term decline in quality of life was the consequence of the burdens that the disease 
placed on the health and socioeconomic status of individuals. A CHD event often involves 
changes to an individual’s lifestyles, therefore recovery from poor quality of life might require 
a long time, especially in those who as a result of the disease have experienced loss of control 
and autonomy. Results of this study provided evidence of lower autonomy among men who 
experienced CHD compared to women. In this sample of older people, the long term decline 
in quality of life could also be partly a consequence of ageing. This is supported by our finding 
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of a decline over time in quality of life among healthy individuals, and it is consistent with 
previous studies reporting a trend of worsening quality of life over time especially at older ages 
(Zaninotto et al., 2009). On the other hand, the improvement in depressive caseness seen in 
women might reflect a process of adaptation to the disease. It is thought that women may 
generally have more effective coping strategies for managing stressful life events than men 
(Hobfoll et al., 1994). In particular, after experiencing myocardial infarction women are more 
likely than men to adopt problem-focused and emotion-focused coping strategies (Bogg et al., 
2000). Learning more about how women cope with CHD may provide lessons that will help 
men adopt more effective strategies for long-term recovery in their quality of life. 
No previous studies have reported a decrease over time in the quality of life of women 
concomitant with a reduction in the risk of reporting 3 or more depressive symptoms. One 
possible explanation might be in the relatively long follow-up of our study. Another possible 
explanation might be that women reported depressive caseness as a consequence of the disease, 
therefore in the long term they might have adjusted to the CHD event and consequently their 
mental health improved.  
 
Study strengths and limitations 
One of the strengths of this study is the use of a large sample of older people living in private 
households in England. The study was designed to collect information on topics necessary to 
understand the economic, social, psychological and health elements of the ageing process. 
Some of the advantages of using this data set include adjustment for several important 
covariates; and the ability to compare the results for the CHD population with those of a 
Healthy group of people of similar age. This allowed us to determine whether patterns of 
change over time were specific to CHD, or reflected more general trends in men and women 
as they grow older.  
Another strength of this study is the use of two distinct measures of well-being. By exploring 
both quality of life and depressive caseness after the CHD event it was possible to untangle 
aspects of people’s well-being never formally identified before. Results from this study 
highlight the difference between these two aspects of people’s well-being and contribute to the 
current debate on the importance of measuring them separately to develop a broader 
appreciation of people’s lives (Dolan et al., 2011; Kahneman et al., 2006). 
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The treatment of missing data constitutes a further strength of this analysis. Missing data 
often occur in epidemiological studies where non-response is a major problem. The 
development of sophisticated missing data techniques allows researchers to improve the 
validity of research results (Sterne et al., 2000). We used a technique to impute missing data 
particularly suitable for repeated measures, the recently developed two-fold fully conditional 
specification (Nevalainen et al., 2009). 
One possible limitation of this analysis is the use of a self-reported measure of CHD. 
Although an objective measure of CHD would have been preferable, a number of validation 
studies have demonstrated that self-reported CHD is reasonably accurate when compared with 
medical records (Lampe  et al., 1999;  Baumeister et al., 2010). Furthermore, no 
allowance was made for the severity of cardiac illness. Some people will have more severe 
CHD than others, but we were unable to take this into account in the analyses. Also, no 
distinction was made between first and recurrent CHD events, so we implicitly assumed that a 
recent recurrence was as important as the first onset.                                                          
Our measure of depression is not designed to detect depressive illness; therefore we were 
unable to account for the severity or the chronicity of depression. However, we believe that 
reporting at least 3 symptoms is valid as a negative indicator of mental health. 
Lastly, the changes in quality of life and depressive caseness were analysed according to 
disease status at baseline. About 3% of people in the Healthy group experienced a CHD event 
after the baseline interview and 7% developed other diseases (such as diabetes, stroke, 
pulmonary disease, Alzheimer, Parkinson’s and cancer). As a consequence, the healthy 
controls were not necessarily free of disease at follow-up. The decision not to exclude people 
that developed a chronic condition at follow-up was made to allow fair comparisons with the 
group of people with CHD, who at subsequent waves have also experienced a chronic condition 
and about 12% of them experienced a repeat CHD event might have affected their quality of 
life and depressive caseness. 
 
CONCLUSIONS 
We found that changes over time in quality of life differed from those for depressive 
caseness after a CHD event. Men’s quality of life declined over time and no changes in 
depressive caseness were found. Women’s quality of life declined slightly only between 
baseline and four year follow-up, while in the same period their risk of having depressive 
caseness diminished. In the long term women with CHD reported higher scores of quality of 
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life than men, and when looking at each domain of quality of life it was found that they reported 
higher scores of Autonomy. No gender differences in depressive caseness were found.  
Our findings might inform caregivers that after CHD the mental health of men in terms of 
depressive caseness does not necessarily deteriorate over time, and the mental health of women 
could even improve in the long term. On the other hand, men seem to be less able to cope with 
the disease in the long term with respect to their quality of life and in particular in the Autonomy 
domain of quality of life. Men’s quality of life should be monitored in the years following the 
event in order to reduce the risk of long term deterioration and to help them to maintain 
autonomy. Health professionals might advise patients and their immediate relatives on 
effective strategies for coping with cardiac events in order to help maintain good mental health 
and quality of life. The findings of this study indicate that the focus of such advice might differ 
between men and women. 
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Table 1 Baseline characteristics by gender and disease status. England 2002-03 
 
Men  
CHD group 
(n=518) 
Men 
Healthy groupa 
(n=1,702)  
Women  
CHD group 
(n=377) 
Women 
Healthy groupa 
(1,899)  
 
Mean (SD) Mean (SD) P-value Mean (SD) Mean (SD) P-value 
Age 68.1 (10.1) 64.5 (9.6) <.001 69.9 (10.2) 63.1 (10.3) <.001 
Quality of life 40.1 (9.5) 44.8 (7.5) <.001 39.3 (9.2) 44.8 (7.6) <.001 
Positive support  26.6 (5.4) 25.9 (5.5) .010 27.9 (5.2) 28.2 (5.2) 0.279 
Close friends  8.1 (6.0) 7.8 (5.3) 0.242 7.8 (5.0) 8.1 (6.0) 0.236 
 %(95%CI) %(95%CI)  %(95%CI) %(95%CI)  
Depressive 
caseness 
22.7 
(20.6; 24.7) 
14.2 
(13.2; 15.1) 
<.001 
 
33.2 
(30.4; 35.9) 
22.5 
(21.4; 23.6) 
<.001 
 
Not cohabiting 
 
26.8 
(24.6; 29.0) 
23.1 
(21.9; 24.2) 
0.084 
 
49.3 
(46.4; 52.3) 
36.7 
(35.5; 38.0) 
<.001 
 
Completely 
retired 
69.6 
(67.3; 71.9) 
45.4 
(44.0; 46.8) 
<.001 
 
68.1 
(65.4; 70.8) 
42.9 
(41.6; 44.2) 
<.001 
 
Otherb 
 
8.7 
(7.3; 10.1) 
5.5 
(4.9; 6.1) 
.001 
 
22.3 
(19.9; 24.7) 
17.9 
(16.9; 18.9) 
<0.05 
 
Low education 
 
47.2 
(44.7; 49.7) 
39.0 
(37.7; 40.4) 
<.001 
 
48.8 
(45.9; 51.7) 
39.1 
(37.8; 40.4) 
<.001 
 
Wealth 5th 
(richest) 
17.0 
(13.7;22.0) 
26.9 
(24.7;29.0) 
<.001 
 
12.7 
(9.4;16.1) 
25.1 
(23.2;27.0) 
<.001 
 
Wealth 4th 
 
18.5 
(16.6; 20.5) 
22.5 
(21.3; 23.6) 
0.053 
 
15.6 
(13.5; 17.8) 
20.0 
(18.9; 21.0) 
.048 
 
Wealth 3rd 
 
19.8 
(17.8; 21.7) 
19.9 
(18.8; 21.0) 
0.960 
 
20.9 
(18.5; 23.2) 
20.5 
(19.5; 21.6) 
0.861 
 
Wealth 2nd 
 
20.7 
(18.6; 22.7) 
18.6 
(17.5; 19.6) 
0.287 
 
19.7 
(17.4; 22.0) 
19.6 
(18.5; 20.6) 
0.964 
 
Wealth 1st 
(poorest) 
23.4 
(21.3; 25.5) 
14.3 
(13.4; 15.3) 
<.001 
 
31.5 
(28.8; 34.2) 
17.2 
(16.3; 18.2) 
<.001 
 
Current smoker 
 
13.8 
(12.1; 15.6) 
16.3 
(15.3; 17.3) 
0.171 
 
14.0 
(11.9; 16.0) 
17.8 
(16.8; 18.8) 
0.074 
 
Physically 
inactive 
69.9 
(67.6; 72.2) 
52.6 
(51.2; 54.0) 
<.001 
 
80.9 
(78.6; 83.2) 
63.1 
(61.8; 64.3) 
 
<.001 
 
Drinks alcohol ≥3 
days a week 
36.3 
(33.9; 38.7) 
43.0 
(41.6; 44.4) 
.007 
 
36.3 
(19.3; 24.2) 
28.8 
(27.6; 30.0) 
.004 
 
Often troubled 
with pain 
26.3 
(24.1; 28.5) 
14.2 
(13.3; 15.2) 
<.001 
 
26.3 
(33.8; 39.4) 
16.3 
(15.4; 17.3) 
<.001 
 
1 or more ADLs 
 
27.8 
(25.6; 30.0) 
10.5 
(9.7; 11.3) 
<.001 
 
33.5 
(30.8; 36.3) 
11.6 
(10.8; 12.5) 
<.001 
 
Notes: a  people that at baseline had never been diagnosed with CHD, stroke, diabetes, hypertension, 
pulmonary disease, Alzheimer, Parkinson’s, cancer or any limiting longstanding illness . b Permanently unable 
to work, not currently in paid employment, looking after home or family. Results based on five imputed data 
sets. 
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Table 2. Changes over time in quality of life among people with CHD and the Healthy group. 
England 2002-03 to 2006-07 
  
CHD group 
(N=895) 
Healthy groupa 
(N=3,601) 
 Coef.
c 
Std. 
Err. P-value Coef.c 
Std. 
Err. P-value 
Fully adjustedb       
Women vs Men (2002-03) 0.83 0.50 0.094 0.24 0.23 0.289 
Women vs Men (2004-05) 1.82 0.50 <0.001 0.49 0.23 0.034 
Women vs Men (2006-07) 1.82 0.50 <0.001 0.42 0.23 0.066 
Estimated average Men (2002-03) 47.38 0.64 <0.001 49.03 0.25 <0.001 
Estimated average Men (2004-05) 46.54 0.62 <0.001 47.92 0.25 <0.001 
Estimated average Men (2006-07) 44.65 0.63 <0.001 46.15 0.25 <0.001 
Between variance 20.65 0.04  19.17 0.02  
Within variance 30.62 0.02  24.95 0.01  
       
Notes: a People that at baseline had never been diagnosed with CHD, stroke, diabetes, hypertension, 
pulmonary disease, Alzheimer, Parkinson’s, cancer or any limiting longstanding illness. b Adjusted 
for age, cohabiting status, employment status, education, wealth, smoking status, physical activity, 
frequency of alcohol consumption, pain, number of limitations with ADLs, depressive caseness.  c 
Estimated using random intercept models with interaction terms between time and sex. Results based 
on five imputed data sets.  
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Table 3. Changes over time in each domain of quality of life among people with CHD and the 
Healthy group. England 2002-03 to 2006-07 
  
CHD group 
(N=895) 
Healthy groupa 
(N=3,601) 
 Men Women P-value Men Women P-value 
Fully adjustedb       
Control       
Estimated average 2002-03 9.77 10.10 0.055 9.78 9.65 0.113 
Estimated average 2004-05 9.53 9.48 0.817 9.62 9.60 0.795 
Estimated average 2006-07 8.75 9.04 0.215 8.93 8.93 0.908 
Autonomy       
Estimated average 2002-03 11.58 11.98 0.027 11.74 11.92 0.026 
Estimated average 2004-05 11.29 11.83 <0.010 11.71 12.06 <0.010 
Estimated average 2006-07 10.84 11.24 <0.001 11.46 11.58 0.326 
Self-realisation       
Estimated average 2002-03 11.67 11.86 0.347 12.00 12.07 0.416 
Estimated average 2004-05 11.42 11.53 0.598 11.84 11.76 0.472 
Estimated average 2006-07 11.07 11.19 0.607 11.49 11.47 0.790 
Pleasure       
Estimated average 2002-03 13.87 14.18 0.104 14.08 14.25 0.013 
Estimated average 2004-05 13.74 13.96 0.240 13.94 14.08 0.148 
Estimated average 2006-07 13.38 13.60 0.398 13.69 13.86 0.057 
Notes: a People that at baseline had never been diagnosed with CHD, stroke, diabetes, hypertension, 
pulmonary disease, Alzheimer, Parkinson’s, cancer or any limiting longstanding illness. b Adjusted 
for age, cohabiting status, employment status, education, wealth, smoking status, physical activity, 
frequency of alcohol consumption, pain, number of limitations with ADLs, depressive symptoms. 
Results based on five imputed data sets. 
Results obtained from random intercept models with interaction terms between time and sex. 
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Table 4. Changes over time in depressive caseness among people with CHD and the Healthy 
group. England 2002-03 to 2006-07 
  
CHD group 
(N=895) 
Healthy groupa 
(N=3,601) 
 OR
c 
Std. 
Err. P-value ORc 
Std. 
Err. P-value 
Fully adjustedb       
Women vs Men (2002-03) 1.99 0.48 <0.010 2.31 0.30 <0.001 
Women vs Men (2004-05) 1.76 0.44 0.023 1.78 0.23 <0.001 
Women vs Men (2006-07) 1.18 0.30 0.517 2.56 0.35 <0.001 
Men’s depression (2002-03) 1   1   
Men’s  depression (2004-05) 1.20 0.24 0.359 1.17 0.14 0.212 
Men’s  depression (2006-07) 1.06 0.22 0.779 0.85 0.11 0.203 
Women’s  depression (2002-03) 1   1   
Women’s  depression (2004-05) 1.06 0.23 0.774 0.90 0.09 0.274 
Women’s  depression (2006-07) 0.63 0.14 0.024 0.94 0.10 0.551 
Between variance 20.65 0.04  19.17 0.02  
Within variance 30.62 0.02  24.95 0.01  
       
Notes: a People that at baseline had never been diagnosed with CHD, stroke, diabetes, hypertension, 
pulmonary disease, Alzheimer, Parkinson’s, cancer or any limiting longstanding illness. b Adjusted for 
age, cohabiting status, employment status, education, wealth, smoking status, physical activity, 
frequency of alcohol consumption, pain,  number of limitations with ADLs. c Estimated using random 
intercept models with interaction terms between time and sex.  Results based on five imputed data sets. 
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Figure 1 Trajectories over time of quality of life among people with CHD and the Healthy 
group, by gender. England 2002-03 to 2006-07 
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Figure 2 Predicted probabilities of depressive caseness among people with CHD and the 
Healthy group, by gender. England 2002-03 to 2006-07 
 
 
